Suppr超能文献

哈萨克族妇女早期乳腺癌遗传易感性的研究。

Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity.

机构信息

Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.

Al-Farabi Kazakh National University, Almaty 050060, Kazakhstan.

出版信息

Oncotarget. 2023 Oct 4;14:860-877. doi: 10.18632/oncotarget.28518.

Abstract

Breast cancer (BC) is the most common type of cancer among women in Kazakhstan. To date, little data are available on the spectrum of genetic variation in Kazakh women with BC. We aimed to identify population-specific genetic markers associated with the risk of developing early-onset BC and test their association with clinical and prognostic factors. The study included 224 Kazakh women diagnosed with BC (≤40 age). Entire coding regions (>1700 exons) and the flanking noncoding regions of 94 cancer-associated genes were sequenced from blood DNA using MiSeq platform. We identified 38 unique pathogenic variants (PVs) in 13 different cancer-predisposing genes among 57 patients (25.4%), of which 6 variants were novel. In total, 12 of the 38 distinct PVs were detected recurrently, including c.5266dup, c.5278-2del, and c.2T>C, and c.9409dup and c.9253del that may be founder in this population. carriers were significantly more likely to develop triple-negative BC (OR = 6.61, 95% CI 2.44-17.91, = 0.0002) and have family history of BC (OR = 3.17, 95% CI 1.14-8.76, = 0.03) compared to non-carriers. This study allowed the identification of PVs specific to early-onset BC, which may be used as a foundation to develop regional expertise and diagnostic tools for early detection of BC in young Kazakh women.

摘要

乳腺癌(BC)是哈萨克斯坦女性中最常见的癌症类型。迄今为止,关于哈萨克族女性 BC 遗传变异谱的数据很少。我们旨在确定与早发性 BC 发病风险相关的人群特异性遗传标志物,并检验其与临床和预后因素的关联。该研究纳入了 224 名哈萨克族女性(≤40 岁)。使用 MiSeq 平台,从血液 DNA 中对 94 个癌症相关基因的整个编码区(>1700 个外显子)和侧翼非编码区进行测序。我们在 57 名患者(25.4%)的 13 个不同的癌症易感基因中发现了 38 个独特的致病性变异(PVs),其中 6 个是新发现的。总共,在 38 个不同的 PVs 中有 12 个是重复出现的,包括 c.5266dup、c.5278-2del、c.2T>C,以及 c.9409dup 和 c.9253del,它们可能是该人群中的 founder 突变。携带这些突变的患者更有可能发展为三阴性乳腺癌(OR = 6.61,95% CI 2.44-17.91, = 0.0002),并且有乳腺癌家族史(OR = 3.17,95% CI 1.14-8.76, = 0.03)。与非携带者相比。这项研究确定了特定于早发性 BC 的 PVs,它们可以作为开发针对年轻哈萨克族女性 BC 的早期检测的区域性专业知识和诊断工具的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c459/10549772/0b0b87933064/oncotarget-14-28518-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验